281 related articles for article (PubMed ID: 15879638)
1. The role of aromatase inhibitor (AI) in the treatment of breast cancer.
Irawan C; Abdulmuthalib
Acta Med Indones; 2005; 37(1):43-8. PubMed ID: 15879638
[No Abstract] [Full Text] [Related]
2. Endocrine therapy for early breast cancer.
Hussain SA; Williams S; Stevens A; Rea DW
Expert Rev Anticancer Ther; 2004 Oct; 4(5):877-88. PubMed ID: 15485321
[TBL] [Abstract][Full Text] [Related]
3. Optimizing adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer: a decision analysis.
Punglia RS; Kuntz KM; Winer EP; Weeks JC; Burstein HJ
J Clin Oncol; 2005 Aug; 23(22):5178-87. PubMed ID: 15998905
[TBL] [Abstract][Full Text] [Related]
4. [New developments in the hormonal treatment of breast cancer in postmenopausal women].
Trunet P; Marty M
Bull Cancer; 1999 Oct; 86(10):815-20. PubMed ID: 10572232
[TBL] [Abstract][Full Text] [Related]
5. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
6. [Tamoxifen in the adjuvant setting for breast cancer: Reflexions about the risk of uterine carcinosarcoma].
Leung F; Terzibachian JJ; Govyadovskiy A; Bourtembourg A; Maillet R; Riethmuller D
Gynecol Obstet Fertil; 2009 May; 37(5):447-51. PubMed ID: 19394886
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibitors--extending the benefits of adjuvant therapy beyond tamoxifen.
Smith IE
Breast; 2004 Dec; 13 Suppl 1():S3-9. PubMed ID: 15585377
[TBL] [Abstract][Full Text] [Related]
8. [New developments in hormonal therapy for breast cancer].
Tominaga T
Gan To Kagaku Ryoho; 1996 May; 23(6):678-83. PubMed ID: 8645017
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
Tuxen MK; Nielsen DL; Lindberg H; Kamby C
Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922
[TBL] [Abstract][Full Text] [Related]
10. Optimizing endocrine therapy for breast cancer.
Winer EP
J Clin Oncol; 2005 Mar; 23(8):1609-10. PubMed ID: 15755964
[No Abstract] [Full Text] [Related]
11. Commentary: optimal adjuvant endocrine therapy of postmenopausal breast cancer.
Cunnick G; Mokbel K
Int J Fertil Womens Med; 2005; 50(5 Pt 1):197-8. PubMed ID: 16468468
[TBL] [Abstract][Full Text] [Related]
12. Current concepts in the endocrine therapy of breast cancer: tamoxifen and aromatase inhibitors.
Singh Ranger G
J Clin Pharm Ther; 2005 Aug; 30(4):313-7. PubMed ID: 15985044
[TBL] [Abstract][Full Text] [Related]
13. The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
Winer E
Clin Adv Hematol Oncol; 2008 Aug; 6(8):573-4. PubMed ID: 18820598
[No Abstract] [Full Text] [Related]
14. By the way, doctor. Should I switch from tamoxifen to an aromatase inhibitor?
Robb-Nicholson C
Harv Womens Health Watch; 2007 Jun; 14(10):8. PubMed ID: 18018318
[No Abstract] [Full Text] [Related]
15. Advances in adjuvant hormonal therapy for postmenopausal women.
Strasser-Weippl K; Goss PE
J Clin Oncol; 2005 Mar; 23(8):1751-9. PubMed ID: 15755983
[No Abstract] [Full Text] [Related]
16. [Assessment of the quality of life of women with breast cancer in adjuvant treatment with tamoxifen or aromatase inhibitors--a randomized trial].
Volovăţ C; Volovăţ SR; Dogaru C; Vulpoi C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):53-7. PubMed ID: 21688560
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H
Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588
[TBL] [Abstract][Full Text] [Related]
18. Progress in tailoring adjuvant endocrine therapy for postmenopausal women with early breast cancer.
Bedard PL; Piccart-Gebhart MJ
Curr Opin Oncol; 2009 Nov; 21(6):491-8. PubMed ID: 19593135
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy with aromatase inhibitors in postmenopausal, estrogen receptor- positive breast cancer patients: upfront or sequential?
Dediu M; Median D; Alexandru A; Vremes G; Gal C; Gongu M
J BUON; 2009; 14(3):375-9. PubMed ID: 19810126
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy with aromatase inhibitors for postmenopausal women with early breast cancer: evidence and ongoing controversy.
Wheler J; Johnson M; Seidman A
Semin Oncol; 2006 Dec; 33(6):672-80. PubMed ID: 17145347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
